News

Insilico Medicine said the orally available drug, ISM8969, was developed using its proprietary Pharma.AI platform. The generative AI-powered solution is used for the design of novel molecules with ...
The search bar, once the starting point for planning a trip, is being replaced by conversational AI that turns static searches into dynamic dialogue. AI agents that can intuitively handle the entire ...
Servion Global Solutions has predicted that by 2025, 95% of customer interactions will be powered by AI. Artificial intelligence is quickly becoming a vital part for almost all businesses around the ...
C-suite leaders enjoy a unique vantage point when it comes to discovering, understanding and harnessing enterprise and industry developments. Here, top executives from Dell, Lenovo, Intuit, SAS and ...
Generative AI was used in the development of a potential drug treatment for a type of liver cancer in less than 30 days − a process that normally takes years.
Generative AI is being hyped across the news, social media, in corporate earnings calls and by CEOs of tech giants who are meeting with government officials to regulate the technology. “There is a ...
Today’s cybersecurity risks are much broader than they have been historically. Our current era is dominated by digital transactions and communications, and more sophisticated cybersecurity challenges ...
AI can help monitor babies' skin to look for eczema, as well as future skin diseases and allergies. Swedish company SciBase has developed a predictive model to detect eczema. The company is ...
Generative AI is poised to significantly disrupt the job market, with the potential to replace up to one-fourth of current jobs globally, according to a report from economists at Goldman Sachs.
The U.K. kicked off its AI Safety Summit with an agreement to commit to designing AI that’s safe and human-centric.
New research from analyst firm Gartner suggests that at least 30% of generative AI businesses currently testing will be abandoned after proof of concept by the end of 2025.